News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Imágenes: Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/11080337/p-91532660-apple-phone-call-recording-update.webp)
![[Imagen: BlackSalmon/Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/11105412/p-1-91539105-first-job-lean-into-emotional-intelligence-to-thrive-e1778518542762.webp)
![[Foto: Freepik/Magnific]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/11122414/hotel-hidro-sustentable-Fast-Company-Mexico-Magnific.jpg)
![[Imagen original: Adobe Stock]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/05/11101354/p-91531823-how-to-navigate-AI-chaos.webp)
